Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compugen (CGEN) Current Deferred Revenue (2016 - 2025)

Compugen's Current Deferred Revenue history spans 9 years, with the latest figure at $11.0 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 13.89% to $11.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.0 million, a 13.89% increase, with the full-year FY2025 number at $11.0 million, up 13.89% from a year prior.
  • Current Deferred Revenue hit $11.0 million in Q4 2025 for Compugen, up from $10.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CGEN hit a ceiling of $29.6 million in Q2 2025 and a floor of $9.6 million in Q1 2025.
  • Historically, Current Deferred Revenue has averaged $13.3 million across 3 years, with a median of $11.0 million in 2025.
  • The widest YoY moves for Current Deferred Revenue: up 162.99% in 2025, down 32.92% in 2025.
  • Tracing CGEN's Current Deferred Revenue over 3 years: stood at $11.1 million in 2023, then dropped by 13.61% to $9.6 million in 2024, then increased by 13.89% to $11.0 million in 2025.
  • Business Quant data shows Current Deferred Revenue for CGEN at $11.0 million in Q4 2025, $10.7 million in Q3 2025, and $29.6 million in Q2 2025.